Caxton Associates (New York)’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,621	Closed	-$665K	–	591
2024 Q2	$665K	Buy	3,621 +2,317	+178%	+$425K	0.02%	297
2024 Q1	$232K	Buy	+1,304	New	+$232K	0.01%	413